Skip to main content

Table 5 Possible tumor-mediated mechanisms of HPD

From: Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know

  1. Peculiar genomic abnormalities in cancer cells as key determinants in triggering HPD upon ICI administration
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us